You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Subunit Vaccine,

Showing 1 - 25 of 8,385
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza Trial in Taizhou (Quadrivalent influenza virus subunit vaccine, Quadrivalent split influenza virus vaccine)

Not yet recruiting
  • Influenza
  • Quadrivalent influenza virus subunit vaccine
  • Quadrivalent split influenza virus vaccine
  • Taizhou, Jiangsu, China
    Ab&b Biotechnology Co., Ltd.JS
Jan 12, 2023

Systemic Lupus Erythematosus Trial in New York, Oklahoma City (Herpes Zoster Subunit (HZ/su) Vaccine, Placebo)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Herpes Zoster Subunit (HZ/su) Vaccine
  • Placebo
  • New York, New York
  • +1 more
Jan 6, 2023

COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

Not yet recruiting
  • COVID-19
  • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • Manila, Philippines
  • +2 more
Jun 21, 2023

Rotavirus Infections, Rotavirus Gastroenteritis Trial in Shangqiu (Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine,

Recruiting
  • Rotavirus Infections
  • Rotavirus Gastroenteritis
  • Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine
  • +2 more
  • Shangqiu, Henan, China
  • +1 more
Jan 31, 2023

Zoster, Systemic Lupus Erythematosus, Vaccine Reaction Trial in Seoul (Shingrix, Placebo)

Recruiting
  • Zoster
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 17, 2023

Plague Trial in Nanjing (plague vaccine(F1+rV))

Active, not recruiting
  • Plague
  • plague vaccine(F1+rV)
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Diseases Control and Prevention
Apr 8, 2022

COVID-19 Trial in Nanjing (recombinant Ad5 vectored COVID-19 vaccine, RBD-based protein subunit vaccine (ZF2001) against

Completed
  • COVID-19
  • recombinant Ad5 vectored COVID-19 vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Diseases Control and Prevention
Mar 28, 2022

Influenza Trial in Bangkok (TetraFluvac TF vaccine, Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023)

Not yet recruiting
  • Influenza
  • TetraFluvac TF vaccine
  • Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
May 30, 2023

COVID-19 Trial in Indonesia (COVID-19 Protein Subunit Recombinant Vaccine, Active Comparator)

Recruiting
  • COVID-19
  • COVID-19 Protein Subunit Recombinant Vaccine
  • Active Comparator
  • Semarang, Central Java, Indonesia
  • +3 more
Jun 26, 2022

COVID-19 Trial in Herston (UQSC2 Vaccine, NVX-CoV2373 vaccine)

Not yet recruiting
  • COVID-19
  • UQSC2 Vaccine
  • NVX-CoV2373 vaccine
  • Herston, Queensland, Australia
    Q-Pharm Pty Ltd (Nucleus Network Brisbane)
Mar 8, 2023

Humoral Immunity Trial in Gomel (Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by

Enrolling by invitation
  • Humoral Immunity
  • Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba)
  • Gomel, Belarus
    Gomel State Medical University
Jan 30, 2023

COVID-19 Trial (SARS-CoV-2 Subunit Recombinant Protein Vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Subunit Recombinant Protein Vaccine
  • (no location specified)
Jul 5, 2023

RESPIRATORY SYNCYTIAL VIRUS (RSV) Trial (Substudy A (Study Intervention), Substudy A (Placebo), Substudy B)

Not yet recruiting
  • RESPIRATORY SYNCYTIAL VIRUS (RSV)
  • Substudy A (Study Intervention)
  • +2 more
  • (no location specified)
Apr 24, 2023

COVID-19 Trial in Bloemfontein, Pretoria, Soweto (Candidate vaccine, SCB-2020S, Candidate vaccine, SCB-2019, Squalene based

Active, not recruiting
  • COVID-19
  • Candidate vaccine, SCB-2020S
  • +3 more
  • Bloemfontein, South Africa
  • +2 more
Oct 18, 2022

COVID-19 Trial in Natal, São Paulo, Rio De Janeiro (AstraZeneca/Fiocruz, Pfizer/Wyeth, Clover SCB-2019)

Not yet recruiting
  • COVID-19
  • AstraZeneca/Fiocruz
  • +2 more
  • Natal, Rio Grande Do Norte, Brazil
  • +2 more
Jul 21, 2022

Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )

Completed
  • Covid19
  • SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
  • Saline placebo
  • Tehran, Iran, Islamic Republic of
    Espinas Palace Hotel
Oct 11, 2022

Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )

Completed
  • Covid19
  • SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
  • Saline placebo
  • Tehran, Iran, Islamic Republic of
    Espinas Palace Hotel
Oct 11, 2022

COVID-19 Trial in Bandung (SARS-CoV-2 subunit protein recombinant vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 subunit protein recombinant vaccine
  • Bandung, Jawa Barat, Indonesia
    Faculty of Medicine Universitas Padjadjaran
Feb 13, 2023

RESPIRATORY SYNCYTIAL VIRUS (RSV) Trial (RSVpreF 120 µg, RSVpreF 60 µg, )

Not yet recruiting
  • RESPIRATORY SYNCYTIAL VIRUS (RSV)
  • RSVpreF 120 µg
  • +2 more
  • (no location specified)
Jun 2, 2023

Respiratory Syncytial Viruses Trial in Canada, United Kingdom, United States (RSVPreF3 OA investigational vaccine, HZ/su

Not yet recruiting
  • Respiratory Syncytial Viruses
  • RSVPreF3 OA investigational vaccine
  • HZ/su vaccine
  • Daphne, Alabama
  • +23 more
Jul 21, 2023

Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)

Not yet recruiting
  • Healthy
  • H107e
  • +10 more
  • Pretoria, Gauteng, South Africa
    Aurum Institute
Sep 24, 2023

Covid19 Trial in Jakarta (SARS-CoV-2 Protein Subunit Recombinant Vaccine, SARS-CoV-2 Inactivated Vaccine)

Completed
  • Covid19
  • SARS-CoV-2 Protein Subunit Recombinant Vaccine
  • SARS-CoV-2 Inactivated Vaccine
  • Jakarta, Greater Jakarta, Indonesia
    Fakultas Kedokteran Universitas Indonesia
Aug 8, 2022

Herpes Zoster Trial in India (HZ/su, Placebo)

Active, not recruiting
  • Herpes Zoster
  • HZ/su
  • Placebo
  • Visakhapatnam, Andhra Pradesh, India
  • +8 more
Jan 6, 2023

COVID-19 Trial in Las Piñas, Manila (Candidate vaccine, SCB-2019, Comirnaty Vaccine, COVID-19 Vaccine Janssen)

Recruiting
  • COVID-19
  • Candidate vaccine, SCB-2019
  • +3 more
  • Las Piñas, Metro Manila, Philippines
  • +1 more
Jul 10, 2022

COVID-19 Trial in Semarang, Jakarta (SARS-CoV-2 protein subunit recombinant vaccine, SARS-CoV-2 inactivated vaccine)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 protein subunit recombinant vaccine
  • SARS-CoV-2 inactivated vaccine
  • Semarang, Central Java, Indonesia
  • +1 more
Aug 8, 2022